“I have never seen medical research progressing as fast as the past three months”

The Covid-19 cell of the intensive care unit of the Bordeaux University Hospital – Mickaël Bosredon / 20 Minutes

  • The director of public health of the ARS warns that it is advisable to remain cautious with the evolution of the epidemic because there may be a second wave.
  • To prepare for progressive deconfinement from May 11, action will have to be taken on three fronts, in particular hygiene measures and the ramp-up of Covid-19 research tests to isolate positive patients.
  • He underlines “some hopes”, concerning certain treatments making it possible to limit the severity of the disease.

Director of public health atNouvelle-Aquitaine Regional Health Agency (ARS), Dr. Daniel Habold took stock this Monday on
the evolution of the epidemic in the region, and the screening measures that will have to be taken in the coming weeks, in connection with the
deconfinement. Here’s what to take away from her speech.

Stay cautious about deconfinement. Even if New Aquitaine remains relatively untouched by the epidemic, the figures “show us that we are not on a peak which is going back down,
but on a platter Insists Dr. Daniel Habold. “The viral circulation in the conditions of confinement that we know today, therefore still exists, which is to say how much we must be careful compared to the deconfinement envisaged from May 11. “

No further patient transfers from other regions are planned. The objective of increasing the number of resuscitation beds “has been achieved” estimates Dr Daniel Habold, “since we still have a third of the beds available in New Aquitaine. “In addition,” to date, there are no plans to transfer resuscitation patients from regions under great strain, but we continue to support them from the point of view of staff and resources. “

Increase in power on virus testing. To prepare for the next phase, that is to say the beginning of deconfinement, “we will have to act on three axes” insists Dr. Daniel Habold. “First, there will be primary prevention, which consists of accentuating hygiene measures, barrier and distancing measures, to limit traffic. “

Secondary prevention will consist of measuring the epidemic in New Aquitaine to detect any new outbreak. This will involve “screening by PCR tests (polymerase chain reaction) on which we will ramp up in the coming weeks. “These tests” will be very largely based on populations who are symptomatic or in contact with Covid patients, in order to search for the virus. “While the refusal to extend this test to asymptomatic people in the population, is currently controversial, Dr. Daniel Habold asserts for his part that a negative Covid test is” useless today “:” On an asymptomatic person there is a good chance that it is negative, which does not mean that she will not catch the disease in the hours that follow, nor that she is not developing it. It is therefore not a protection passport that would allow you to return to your work station. The positive test, on the other hand, will bring about two fundamental elements: the isolation of the sick person, and the tracing of the people they may have met in the previous 48 hours. “We have been doing it since the start of the crisis, and that’s how we managed to stifle all the homes, but doing it across New Aquitaine is going to be a real challenge. “

Finally, tertiary prevention consists in continuing to mobilize the intensive care beds. “After the wave, there may be a wavelet, or even a second wave, warns Dr. Daniel Habold, so we must remain vigilant. “The director of public health also spoke of” some hopes “regarding treatments” to limit the severity of the disease and therefore limit mortality and patients being resuscitated “. “We are only at the beginning,” he continues, “but I have never seen medical research progressing as fast as the past three months, that gives hope for the months to come.” “



Read Also:  The market is closed! Villagers set up a stall to rent Phrae. Old-fashioned goods for sale on the street preserve life
Share on facebook
Share on pinterest
Share on twitter
Share on linkedin
Share on email


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.